Gilad Itchaki Selected Research

Gilad Itchaki Research Topics

Disease

8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 10/2016
6	COVID-19 10/2023 - 01/2020
5	Infections 11/2022 - 07/2013
4	Lymphoma (Lymphomas) 04/2022 - 03/2014
3	Neoplasms (Cancer) 03/2024 - 12/2021
3	Hematologic Neoplasms (Hematological Malignancy) 10/2023 - 07/2021
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2022 - 01/2021
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2016 - 03/2014
2	Neutropenia 12/2021 - 03/2014
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2020 - 01/2019
2	Cytopenia 01/2018 - 07/2013
1	Ovarian Neoplasms (Ovarian Cancer) 03/2024
1	Histiocytosis 12/2023
1	Pneumonia (Pneumonitis) 11/2022
1	Virus Diseases (Viral Diseases) 11/2022
1	Hemorrhage 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Febrile Neutropenia 12/2021
1	Hypertension (High Blood Pressure) 12/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2016
1	Leukemia 10/2016
1	Immunoglobulin Light-chain Amyloidosis 02/2016
1	Multiple Myeloma 03/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2014
1	Hodgkin Disease (Hodgkin's Disease) 01/2014
1	Hypothermia 01/2014
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2013
1	Cardiotoxicity 07/2013

Drug/Important Bio-Agent (IBA)

3	Oxygen (Dioxygen)IBA 01/2022 - 01/2020
3	ibrutinibIBA 01/2020 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2016
2	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2022 - 03/2016
2	BNT162 VaccineIBA 01/2022 - 01/2022
2	Rituximab (Mabthera)FDA Link 12/2021 - 01/2021
2	obinutuzumabIBA 12/2021 - 01/2020
1	Biomarkers (Surrogate Marker)IBA 03/2024
1	EnzymesIBA 03/2024
1	Iodide Peroxidase (Deiodinase)IBA 03/2024
1	Phosphotransferases (Kinase)IBA 12/2023
1	SteroidsIBA 11/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2022
1	Chimeric Antigen ReceptorsIBA 04/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	AlbuminsIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	VaccinesIBA 01/2022
1	AntibodiesIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	remdesivirIBA 12/2021
1	P-SelectinIBA 07/2021
1	MucinsIBA 07/2021
1	LigandsIBA 07/2021
1	polatuzumab vedotinIBA 01/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2020
1	Chlorambucil (Leukeran)FDA Link 01/2020
1	6-bromo-2-naphthyl sulfate (BNS)IBA 01/2019
1	serum P-component (CIt)IBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 05/2017
1	venetoclaxIBA 10/2016
1	Immunoglobulins (Immunoglobulin)IBA 02/2016
1	Bortezomib (Velcade)FDA Link 02/2016
1	Filgrastim (Neupogen)FDA Link 03/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2014
1	AnthracyclinesIBA 07/2013

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 11/2022 - 07/2013
3	Therapeutics 10/2023 - 01/2021
1	Injections 01/2022
1	Critical Care (Surgical Intensive Care) 01/2020
1	Salvage Therapy 03/2016
1	Induction Chemotherapy 01/2016
1	Cell Transplantation 03/2014